Active ingredients: telbivudine
What it is used for
SEBIVO (telbivudine) is indicated for the treatment of HBeAg-positive and HBeAg-negative chronic hepatitis B in patients who have compensated liver disease, evidence of viral replication and active liver inflammation and who are nucleoside analogue naive. The following points should be considered when initiating therapy with Sebivo:,. For HBeAg-positive patients, Sebivo treatment should only be initiated in patients with baseline HBV DNA < 9log 10 copies/mL and baseline ALT greater than or equal to 2x ULN.,. For HBeAg-negative patients, Sebivo treatment should only be initiated in patients with baseline HBV DNA < 7log 10 copies/mL.
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
- The way to take this medicine: Oral
- Store below 30 degrees Celsius
- Protect from Moisture
- Shelf lifetime is 3 Years.
Always read the label. If symptoms persist see your healthcare professional.
Oval, white to slightly yellowish, marked LDT on one side.
Images are the copyright of the Pharmacy Guild of Australia
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Pregnant or planning a pregnancy?
For the active ingredient telbivudine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems